Team-based care for hard-to-heal ulcers, including diabetic foot ulcers
Compares team care with usual care for hard-to-heal ulcers in adults.
Key facts
- Who runs it
- Nordsjaellands Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 1 Aug 2026
- Expected to end
- 31 Oct 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- coordinated primary-care-based MDT-model
- Standard Care (in control arm)
- Record updated
- 5 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with hard-to-heal ulcers (wounds that do not heal well). It compares care by a team of hospital and local wound staff with standard care.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- One or more hard-to-heal ulcers.
- Earlier treatment
- People cannot join if they had a procedure to restore blood flow (revascularization) in the affected limb within the 4 weeks before screening, or have one planned. People who had a major amputation on either leg before cannot join.
- Biomarker or test result
- Toe blood pressure must not be below 35mmHg.
Main reasons for not taking part
- Toe blood pressure < 35mmHg
- Ulcer infection needing surgery within seven days
- Prior major amputation on the affected or the other leg
- Current treatment with cytotoxic drugs or glucocorticoids taken by mouth or injection
- Taking part in another ulcer-healing trial within the 4 weeks before screening
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Patients aged 18 years or above
- Hard-to-heal ulcer(s)
- Able to understand written and oral information
- Ability to follow planned visits and treatment
- Able to provide informed consent in Danish and/or English
Who cannot take part
- Revascularization procedure in the affected limb planned, or undertaken within the 4 weeks prior to screening
- Prior major amputations on affected or contralateral leg
- Current treatment with cytotoxic drugs or with systemically administered glucocorticoids
- Participation in another interventional ulcer-healing trial within the 4 weeks prior to screening
- Prior enrolment in this trial
- Infections of the ulcer needing acute or sub-acute (defined as within seven days) surgical treatment
- Toe blood pressure < 35mmHg
- Likely inability to comply with the need for planned visits because of planned activities
- Judgement by the investigator that the patient does not have the capacity to understand the study procedures or provide written informed consent
This trial is currently available in Denmark.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The TSS project is a study of the effects of treating hard-to-heal ulcers in a multidisciplinary cross sectional team, meaning that nurse and doctor from a hospital based wound healing clinic and wound care nurse from the primary care sector treat the patient in collaboration rather than the current form where care in municipalities and hospital setting, communicate but treat the patient on their own. The study is designed as a randomized study, meaning that individuals with hard-to-heal ulcers are randomly designated to standard care or the multidis-ciplinary team. We measure several aspects of the new format, but the main outcome com-pared between the two groups (standard care and multidisciplinary care) is number of ulcers healed.
Read full original descriptionShow less
Participants are followed for a year after inclusion in the study, and have 6 fixed visits in the clinic, with the possibility of more visits if necessary.
There is no "new" medicine, surgery or other treatments planned in the study, but the multi-disciplinary team can offer and implement any treatment deemed appropriate for the individ-ual that is allocated to the multidisciplinary team, of course the individual has the opportunity to decline any treatment offered by the team. The control group, i.e. individuals allocated to standard care, will receive the treatment that is normally available to individuals with hard-to-heal ulcers treated in the municipality, including referral to hospital based treatments.
The 2 groups in the trial
- coordinated primary-care-based MDT-modelTreatment being tested
The proposed intervention consists of an MDT with an orthopedic surgeon (Jonas Askø Andersen) and a wound care nurse from the wound clinical at North Zealand Hospital as well as a wound care nurse from the primary sector. Participants who are randomized to intervention is offered treatment in the team as deemed appropriate by the MDT. The participant will be seen in the clinic (in the primary sector) for planned study visits at. 1\. Week 1 2. Week 4 3. 3 months 4. 6 months 5. 12 months 6. Extra study visits can be planned as deemed necessary for the individual participant between the above outlined visits Weekly visits in the clinic for bandage changes and standard wound care is planned as deemed relevant by the MDT team for the individual participant. The visits are performed by wound care nurses in the primary sector If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing, the participant is pla
- Standard CareExisting treatment, for comparison
Participants randomized to control are not invited to be seen by the MDT team but are attended by the wound care nurse from the primary sector as part of the standard treatment offered to individuals with ulcers in the municipality. Apart from planned visits at 3, 6 and 12 months, the frequency and number of visits in the study period is performed as deemed appropriate by the wound care nurses from the primary sector. If any outcomes relevant for the study occurs outside of the planned study visits i.e., ulcer healing, infections or recurrence following healing date of event is noted.
Treatment: Standard Care (in control arm)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers; a Randomized Clinically Controlled Trial
- Plain-language title
- Team-based care for hard-to-heal ulcers, including diabetic foot ulcersGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 5 August 2026